Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2007

Open Access 01-12-2007 | Original investigation

The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates

Authors: Fatma Al-Maskari, Mohammed El-Sadig, John N Norman

Published in: Cardiovascular Diabetology | Issue 1/2007

Login to get access

Abstract

Background

Diabetes Mellitus (DM) is a major public health problem in the UAE with a prevalence rate reaching 24% in national citizens and 17.4% in expatriates. The aim of this study was to determine the prevalence and risk factors of macrovascular complications among diabetic patients in the Al-Ain district of the United Arab Emirates (UAE).

Methods

The study was part of a general cross-sectional survey carried out to assess the prevalence of diabetes (DM) complications among known diabetic patients in Al-Ain District, UAE. Patients were randomly selected during 2003/2004. Patients completed an interviewer-administered questionnaire carried out by treating doctors and underwent a complete medical assessment including measurement of height, weight, blood pressure and examination for evidence of macrovascular complications. A standard ECG was recorded and blood samples were taken to document fasting blood sugar, glycosylated haemoglobin (HbA1C) and lipid profile.

Results

A sample of 513 diabetic patients was selected with a mean age of 53 years (SD ± 13.01). Overall, 29.5% of DM patients had evidence of macrovascular complications: 11.6% (95% CI: 8.8–14.4) of patients had peripheral vascular disease (PVD), 14.4% (95% CI: 11.3–17.5) had a history of coronary artery disease (CAD) and 3.5% (95% CI: 1.9–5.1%) had cerebrovascular disease (CVD). Of the total population surveyed 35% (95%CI: 30.8–39) had hypertension. The analysis showed that macrovascular complications in diabetic patients were more common among males, increased with age, were more common among hypertensive patients and its prevalence increased steadily with duration of DM.

Conclusion

Our data revealed a significant association between hypertension and presence of macrovascular disease among diabetic patients. However, the risk of CAD in the UAE was relatively low compared to that seen in patients in other geographical settings. In addition, a lack of correlation between macrovascular disease and glycemic control among patients with DM was observed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Adler AI, Neil HA, Manley SE, Holman RR, Turner RC: Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J. 1999, 138 (5Pt 1): S353-9. 10.1016/S0002-8703(99)70035-9.CrossRefPubMed Adler AI, Neil HA, Manley SE, Holman RR, Turner RC: Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J. 1999, 138 (5Pt 1): S353-9. 10.1016/S0002-8703(99)70035-9.CrossRefPubMed
4.
go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 364 (9438): 937-52. 10.1016/S0140-6736(04)17018-9. 2004 Sep 11–17 Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 364 (9438): 937-52. 10.1016/S0140-6736(04)17018-9. 2004 Sep 11–17
5.
go back to reference Tan MH, MacLean DR: Epidemiology of diabetes mellitus in Canada. Clin Invest Med. 1995, 18 (4): 240-6.PubMed Tan MH, MacLean DR: Epidemiology of diabetes mellitus in Canada. Clin Invest Med. 1995, 18 (4): 240-6.PubMed
6.
go back to reference Macrovascular disease in diabetes : Pathophysiology and management . Canadian Diabetes. 1998, 11 (2): 2-8. Macrovascular disease in diabetes : Pathophysiology and management . Canadian Diabetes. 1998, 11 (2): 2-8.
7.
go back to reference O'Brien JA, Patrick AR, Caro JJ: Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res. 3 (1): 7-10.1186/1472-6963-3-7. 2003 Mar 21 O'Brien JA, Patrick AR, Caro JJ: Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res. 3 (1): 7-10.1186/1472-6963-3-7. 2003 Mar 21
8.
go back to reference Park K: Park's Textbook of Preventive and Social Medicine. 2002, 17 Park K: Park's Textbook of Preventive and Social Medicine. 2002, 17
9.
go back to reference World Health Organisation: Definitions, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. WHO/NCD/NCS/99.2. Geneva; WHO World Health Organisation: Definitions, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. WHO/NCD/NCS/99.2. Geneva; WHO
10.
go back to reference Jacques Wallach: Interpretation of Diagnostic Tests. 2006, 8 Jacques Wallach: Interpretation of Diagnostic Tests. 2006, 8
11.
go back to reference World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report, Geneva, WHO Technical Report Series. 1980, 646: 8-12. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report, Geneva, WHO Technical Report Series. 1980, 646: 8-12.
12.
go back to reference Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H: Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia. 1991, 34 (8): 590-4. 10.1007/BF00400279.CrossRefPubMed Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H: Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia. 1991, 34 (8): 590-4. 10.1007/BF00400279.CrossRefPubMed
13.
go back to reference Elbagir MN, Eltom MA, Mahadi EO, Berne C: Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract. 1995, 30 (1): 59-67. 10.1016/0168-8227(95)01146-3.CrossRefPubMed Elbagir MN, Eltom MA, Mahadi EO, Berne C: Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract. 1995, 30 (1): 59-67. 10.1016/0168-8227(95)01146-3.CrossRefPubMed
14.
go back to reference Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993, 36 (11): 1175-84. 10.1007/BF00401063.CrossRefPubMed Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993, 36 (11): 1175-84. 10.1007/BF00401063.CrossRefPubMed
15.
go back to reference Cea-Calvo L, Conthe P, Gomez-Fernandez P, de Alvaro F, Fernandez-Perez C, RICARHD investigators: Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain : a cross-sectional study. Cardiovasc Diabetol. 5: 23-10.1186/1475-2840-5-23. 2006 Nov 3 Cea-Calvo L, Conthe P, Gomez-Fernandez P, de Alvaro F, Fernandez-Perez C, RICARHD investigators: Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain : a cross-sectional study. Cardiovasc Diabetol. 5: 23-10.1186/1475-2840-5-23. 2006 Nov 3
16.
go back to reference Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H: Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol. 5: 15-10.1186/1475-2840-5-15. 2006 Jul 17 Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H: Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol. 5: 15-10.1186/1475-2840-5-15. 2006 Jul 17
17.
go back to reference Hanefeld M, Koehler C, Gallo S, Benke I, Ott P: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 6 (13): 2007 Apr 26 Hanefeld M, Koehler C, Gallo S, Benke I, Ott P: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 6 (13): 2007 Apr 26
18.
go back to reference UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 317 (7160): 703-13. Erratum in: BMJ. 1999 Jan 2;318(7175):29.1998 Sep 12 UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 317 (7160): 703-13. Erratum in: BMJ. 1999 Jan 2;318(7175):29.1998 Sep 12
19.
go back to reference Nazimek-Siewniak B, Moczulski D, Grzeszczak W: Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design. J Diabetes Complications. 2002, 16 (4): 271-6. 10.1016/S1056-8727(01)00184-2.CrossRefPubMed Nazimek-Siewniak B, Moczulski D, Grzeszczak W: Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design. J Diabetes Complications. 2002, 16 (4): 271-6. 10.1016/S1056-8727(01)00184-2.CrossRefPubMed
20.
go back to reference Petersson H, Daryani A, Riserus U: Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovasc Diabetol. 6: 10-10.1186/1475-2840-6-10. 2007 Mar 28 Petersson H, Daryani A, Riserus U: Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovasc Diabetol. 6: 10-10.1186/1475-2840-6-10. 2007 Mar 28
21.
go back to reference Lubree HG, Rege SS, Bhat DS, Raut KN, Panchnadikar A, Joglekar CV, Yajnik CS, Shetty P, Yudkin J: Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr Bull. 2002, 23 (3 Suppl): 146-9.PubMed Lubree HG, Rege SS, Bhat DS, Raut KN, Panchnadikar A, Joglekar CV, Yajnik CS, Shetty P, Yudkin J: Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr Bull. 2002, 23 (3 Suppl): 146-9.PubMed
22.
go back to reference Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985, 34 (10): 1055-1058. 10.2337/diabetes.34.10.1055.CrossRefPubMed Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985, 34 (10): 1055-1058. 10.2337/diabetes.34.10.1055.CrossRefPubMed
23.
go back to reference Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed). 1984, 288 (6428): 1401-1404.CrossRef Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed). 1984, 288 (6428): 1401-1404.CrossRef
24.
go back to reference Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B: Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004, 27 (8): 2041-2046. 10.2337/diacare.27.8.2041.CrossRefPubMed Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B: Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004, 27 (8): 2041-2046. 10.2337/diacare.27.8.2041.CrossRefPubMed
25.
go back to reference Barnett E, Casper ML, Halverson JA, Elmes GA, Braham VE, Majeed ZA, Bloom AS, Stanley S: Men and Heart Disease: An Atlas of Racial and Ethnic Disparities in Mortality. 2001, Morgantown, WV: Office for Social Environment and Health Research, West Virginia University, 1 Barnett E, Casper ML, Halverson JA, Elmes GA, Braham VE, Majeed ZA, Bloom AS, Stanley S: Men and Heart Disease: An Atlas of Racial and Ethnic Disparities in Mortality. 2001, Morgantown, WV: Office for Social Environment and Health Research, West Virginia University, 1
27.
go back to reference Matthews KA, Sowers MF, Derby C, Stein E, Miracle-McMahill H, Crawford S: Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of women's health across the nation. Am Heart J. 2005, 149: 1066-2005. 10.1016/j.ahj.2004.08.027.CrossRefPubMed Matthews KA, Sowers MF, Derby C, Stein E, Miracle-McMahill H, Crawford S: Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of women's health across the nation. Am Heart J. 2005, 149: 1066-2005. 10.1016/j.ahj.2004.08.027.CrossRefPubMed
Metadata
Title
The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates
Authors
Fatma Al-Maskari
Mohammed El-Sadig
John N Norman
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2007
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-6-24

Other articles of this Issue 1/2007

Cardiovascular Diabetology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.